Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

584
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
584
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

753
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
753
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

627
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
627
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

440
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
440
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

725
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
725
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

732
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
732

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac care of athletes with disabilities: are we prepared to adapt?

British journal of sports medicine·2026
Same author

Need to train clinicians for physical activity and exercise interventions: a call to action.

British journal of sports medicine·2026
Same author

Implementing brain health strategies in primary care: methods and baseline findings from the BHAM registry.

Archives of public health = Archives belges de sante publique·2025
Same author

Charting the Future: Progress in the National Family Medicine Research Strategy.

Annals of family medicine·2025
Same author

A Fatal Case of Powassan Virus Encephalitis.

Journal of Brown hospital medicine·2025
Same author

Transforming Family Medicine Research: Strategic Planning, Summits, and a Special Issue.

Journal of the American Board of Family Medicine : JABFM·2024

Related Experiment Video

Updated: Mar 18, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.4K

Cardiomyopathy: A Guide for Primary Care.

Joseph Coppiano1, Mark Carrasco2, Irfan Asif1

  • 1University of Alabama at Birmingham.

American Family Physician
|March 16, 2026
PubMed
Summary

This review explores nonischemic cardiomyopathies, heart muscle diseases with varied causes and symptoms. Early diagnosis and tailored management, including medical therapy and risk stratification, are crucial for improving patient outcomes.

More Related Videos

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice
04:45

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice

Published on: May 5, 2022

3.1K
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

12.3K

Related Experiment Videos

Last Updated: Mar 18, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.4K
Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice
04:45

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice

Published on: May 5, 2022

3.1K
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

12.3K

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Cardiomyopathy involves myocardial structural and functional abnormalities.
  • Nonischemic causes are the focus, presenting diverse clinical scenarios.
  • Symptoms vary by type, including dyspnea, fatigue, arrhythmia, and syncope.

Purpose of the Study:

  • To review the nonischemic etiologies of cardiomyopathy.
  • To outline diagnostic evaluations and management strategies.
  • To highlight risk stratification and advanced treatment options.

Main Methods:

  • Literature review focusing on nonischemic cardiomyopathies.
  • Analysis of classification, presentation, and symptomatology.
  • Synthesis of current diagnostic and therapeutic guidelines.

Main Results:

  • Cardiomyopathies are classified as primary or secondary.
  • Hypertrophic cardiomyopathy is the most common primary type.
  • Evaluation involves history, physical exam, ECG, and advanced imaging.

Conclusions:

  • Management is type-specific, including guideline-directed medical therapy and arrhythmia control.
  • Risk stratification for implantable cardioverter-defibrillators is vital for hypertrophic cardiomyopathy.
  • Heart transplantation is an option for advanced disease stages.